Expectations trend
FY2028 · fiscal year ending 2028-06-30 · fmp
Research Solutions Inc/CA (RSSS)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
$1.860.00%
Close 2026-11-04 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.17 → 0.17 EPS · FY ending Jun 30, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for RSSS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
EPS at or above $0.15 in fiscal 2027 | A primary condition in Research Solutions Inc/CA's published investment case. The stated target is >= $0.15. | Broken | EPS falls below $0.15 in FY27 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-06-30 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a small-cap growth business with a recurring-revenue model and improving profitability. Its multi-year view remains intact, though recent momentum has weakened and the next results carry meaningful execution risk.
RSSS is assessed as cheap versus peers, while the priced-in tag is justified and fragility is low. The expectations gap is negative, so the evidence points to room for expectations to be revised lower rather than an easy bar to clear.
Over the past year, total annual recurring revenue, or expected yearly revenue from ongoing subscriptions, grew 7.8%, while B2B recurring revenue grew 14.1%; net income and adjusted EBITDA also increased. Cash from operations declined, recent financial performance is neutral, and momentum weakened sharply; with recent misses and a 43% estimated miss probability, near-term execution remains a concern.
The key company-specific swing factor is whether management sustains recurring-revenue growth and profitability without cutting guidance on the next call. A guidance cut would be a meaningful negative; rate cuts or steadier results and guidance from major technology companies could improve the sector backdrop.
For the next 1 to 3 years, the thesis rests on recurring-revenue growth and better profitability continuing, while cash generation and near-term execution remain watchpoints. The evidence supports an intact but higher-risk multi-year view. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Free cash flow is expected above $7 million. |
| Intact |
| Free cash flow falls below $7 million in FY25 |
Free cash flow: $1.764M FY2026-Q4; GAAP. Published target: >= $7 million. Annual target cannot be compared with a quarterly or TTM observation. Sep 11, 20261,764,109 USD · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue at or above $49 million in fiscal 2025 | Free cash flow is expected above $7 million. | Intact | Revenue falls below $49.1 million in FY25 | Revenue: $12.081M FY2026-Q4; GAAP. Published target: >= $49.1 million. Annual target cannot be compared with a quarterly or TTM observation. Sep 11, 202612,080,560 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.14 → $0.17 · observed estimates
$0.05B → $0.05B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-07-25 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-07-26 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-07-27 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-07-28 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-07-29 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-07-30 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-07-31 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-01 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-02 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-03 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-04 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-05 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-06 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-08 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-09 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-10 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-12 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-13 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-14 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-15 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-16 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-17 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-18 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-19 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-20 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-21 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-22 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-23 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-24 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-25 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-26 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-27 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-28 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-29 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-30 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-08-31 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-01 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-02 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-03 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-04 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-05 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-06 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-07 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-08 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-09 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-10 | $0.14 | $50,347,000 | 1 / 1 |
| 2026-09-11 | $0.14 | $49,936,300 | 1 / 1 |
| 2026-09-12 | $0.14 | $49,936,300 | 1 / 1 |
| 2026-09-13 | $0.14 | $49,936,300 | 1 / 1 |
| 2026-09-14 | $0.14 | $49,936,300 | 1 / 1 |
| 2026-09-15 | $0.14 | $49,936,300 | 1 / 1 |
| 2026-09-16 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-17 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-18 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-19 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-20 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-21 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-22 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-23 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-24 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-25 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-26 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-27 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-28 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-29 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-09-30 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-01 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-02 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-03 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-04 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-05 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-06 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-07 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-08 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-09 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-10 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-11 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-12 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-13 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-14 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-15 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-16 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-17 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-18 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-19 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-20 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-21 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-22 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-23 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-24 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-25 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-26 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-27 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-28 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-29 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-30 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-10-31 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-11-01 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-11-02 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-11-03 | $0.17 | $51,518,150 | 1 / 1 |
| 2026-11-04 | $0.17 | $51,518,150 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 3 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.